Paradigm is building the platform to empower the future of clinical trials. We’re transforming a fragmented and inefficient approach to clinical research into a high-performance trial ecosystem. Our platform will accelerate recruitment, speed study-related insights, automate operations, and make it easy for any physician anywhere to evaluate patients for clinical trials.

industries

Advancing Human Health

Milestones

Lux investment: 2023

Founders

Kent Thoelke

Jonathan Hirsch

‍

Lux partners

No items found.

Open Positions

Visit Website

Paradigm

Similar companies

Eikon Therapeutics

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

josh-wolfe

Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2019

Founders

Eric Betzig

Robert Tjian

Luke Lavis

Xavier Darzacq

Lux partners

view company profile

{name}

Kallyope

Biology + Biochemistry

Advancing Human Health

josh-wolfe

Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic and nutritional product potential of the gut-brain axis.

industries

Biology Biochemistry

Advancing Human Health

Milestones

Lux founded: 2015

Founders

Richard Axel

Tom Maniatis

Charles Zuker

Nancy Thornberry

Lux partners

view company profile

{name}

Benchling

Advancing Human Health

Progressing Science + Knowledge

brandon-reeves

Benchling is transforming research and development with the industry's most widely adopted Life Sciences R&D Cloud.

industries

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2020

Founders

Saji Wickramasekara

Ashu Singhal

Lux partners

view company profile

{name}

Recursion Pharma

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2016

IPO: 2021

Founders

Chris Gibson, PhD

Blake Borgeson, PhD

Dean Li, PhD

Lux partners

view company profile

{name}

Maven

Advancing Human Health

deena-shakir

Maven is the largest virtual clinic for women's and family health.

industries

Advancing Human Health

Milestones

Lux investment: 2021

Founders

Lux partners

view company profile

{name}

Auris Health

Engineering + Electronics

Advancing Human Health

Increasing Productivity + Efficiency

peter-hebert

Auris Healthis an ambitious robotics company based in Silicon Valley. Auris was acquired for up to $6.1B by Johnson & Johnson in 2019.

industries

Engineering Electronics

Advancing Human Health

Increasing Productivity Efficiency

Milestones

Lux investment: 2012

Acquired by JNJ: 2019

Founders

Fred Moll

Lux partners

view company profile

{name}

Cajal Neuroscience

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

josh-wolfe,ian-peikon

Cajal Neuroscienceis a drug discovery company focused on neurodegenerative disease.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2020

Founders

Ian Peikon, PhD

Charles Zuker, PhD

Huda Zoghbi, MD

Tony Zador, MD, PhD

Rob Hershberg, MD, PhD

Andrew Dervan, MD

Lux partners

view company profile

{name}

A-Alpha Bio

Biology + Biochemistry

Advancing Human Health

Progressing Science + Knowledge

9999

shaq-vayda

A-Alpha Bio is building a high-resolution model of biology by measuring protein interactions.

industries

Biology Biochemistry

Advancing Human Health

Progressing Science Knowledge

Milestones

Lux investment: 2021

Founders

David Younger

Randolph Lopez

Lux partners

view company profile

{name}